Clinical Trial of OPB-111077 in Patients With Relapsed or Refractory Acute Myeloid Leukaemia
Condition(s):Acute Myeloid LeukemiaLast Updated:February 15, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Acute Myeloid LeukemiaLast Updated:February 15, 2021Completed
Condition(s):Acute Myeloid LeukemiaLast Updated:July 6, 2022Recruiting
Condition(s):Leukemia, Myeloid, AcuteLast Updated:August 9, 2023Completed
Condition(s):Leukemia, Myeloid, AcuteLast Updated:February 22, 2018Unknown status
Condition(s):Acute Myeloid Leukemia RefractoryLast Updated:December 1, 2023Recruiting
Condition(s):Acute Myeloid Leukemia; Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN); Relapse Leukemia; Refractory LeukemiaLast Updated:August 30, 2023Recruiting
Condition(s):Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, AcuteLast Updated:April 18, 2023Recruiting
Condition(s):Leukemia, Myeloid, AcuteLast Updated:October 17, 2023Active, not recruiting
Condition(s):Acute Myeloid LeukemiaLast Updated:November 7, 2023Completed
Condition(s):Leukemia, Myeloid, AcuteLast Updated:October 11, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.